In silico design of the multi-epitope vaccine for lung adenocarcinoma based on hub gene-derived neoantigens

Abstract Background Lung adenocarcinoma (LUAD) is the most prevalent and lethal subtype of non-small cell lung cancer (NSCLC), characterized by an unfavorable 5-year survival rate ranging from 10% to 20%. Neoantigen-based vaccine platforms show encouraging benefits for NSCLC patients. However, the v...

Descrición completa

Detalles Bibliográficos

Principais autores:	Shaoshuai Li, Minjia Huang, Liqiu Jia, Siyu Liu, Xueting Sun, Daxia Cai, Yanping Su, Minjiang Chen, Chenying Lu, Jiansheng Huang, Jianfei Tu, Jiansong Ji
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2026-03-01
Series:	BMC Cancer
Assuntos:	Neoantigen Multi-epitope vaccine Hub gene Immunoinformatics Reverse vaccinology In silico
Acceso en liña:	https://doi.org/10.1186/s12885-026-15765-1
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!